Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Stimulants are considered the first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD) in the US and they are used in other indications. Stimulants are also diverted for non-medical purposes. Ethnic and regional differences in ADHD diagnosis and in stimulant use have been identified in earlier research. The objectives of this report were to examine the pharmacoepidemiological pattern of these controlled substances over the past decade and to conduct a regional analysis. METHODS: Data (drug weights) reported to the US Drug Enforcement Administration's Automation of Reports and Consolidated Orders System for four stimulants (amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine) were obtained from 2006 to 2016 for Unites States/Territories. Correlations between state level use (mg/person) and Hispanic population were completed. RESULTS: Amphetamine use increased 2.5 fold from 2006 to 2016 (7.9 to 20.0 tons). Methylphenidate use, at 16.5 tons in 2006, peaked in 2012 (19.4 tons) and subsequently showed a modest decline (18.6 tons in 2016). The consumption per municipality significantly increased 7.6% for amphetamine and 5.5% for lisdexamfetamine but decreased 2.7% for methylphenidate (all p < .0005) from 2015 to 2016. Pronounced regional differences were also observed. Lisdexamfetamine use in 2016 was over thirty-fold higher in the Southern US (43.8 mg/person) versus the Territories (1.4 mg/person). Amphetamine use was about one-third lower in the West (48.1 mg/person) relative to the Northeastern (75.4 mg/person, p < .05) or the Midwestern (69.9 mg/person, p ≤ .005) states. States with larger Hispanic populations had significantly lower methylphenidate (r(49) = -0.63), lisdexamfetamine (B, r(49) = -0.49), and amphetamine (r(49) = -0.43) use. CONCLUSIONS: Total stimulant usage doubled in the last decade. There were dynamic changes but also regional disparities in the use of stimulant medications. Future research is needed to better understand the reasons for the sizable regional and ethnic variations in use of these controlled substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
Health Care Spending in the United States and Other High-Income Countries
Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018) · JAMA · doi:10.1001/jama.2018.1150 · Cited by 1,626
Prevalence of Obesity and Severe Obesity in US Children, 1999–2016
Skinner, A. C., Ravanbakht, S. N., Skelton, J. A., Perrin, E. M., & Armstrong, S. C. (2018) · Pediatrics · doi:10.1542/peds.2017-3459 · Cited by 1,412
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1417860 · Cited by 1,181
Research works printed but not linked: 2
- 65. Jachimowicz G, Geiselman RE. Comparison of ease of falsification of Attention Deficit Hyperactivity Disorder diagnosis using standard behavioral rating scales. Cognitive Science Online. 2004; 2:6-20.
- 70. National Academies of Sciences, Engineering, and Medicine. 2015. Mental disorders and disabilities among low-income children. Washington, DC: The National Academies Press.
Cited by
Items 101–186 of 186
Yan, Y., Chen, Q., Nasir, R., Griffin, P. M., Bone, C., & Tuan, W. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109870 · Cited by 2
The Association Between Stimulant Medication Use and Mortality
Morrow, J., Moreton, U., Xu, T., Tatonetti, N. P., Wang, Y., & Walsh, B. T. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002066 · Cited by 2
Howard, J., & Schulte, P. A. (2025) · American Journal of Industrial Medicine · doi:10.1002/ajim.70042 · Cited by 2
Green, M. A., Crawford, J. L., Kuhnen, C. M., Samanez-Larkin, G. R., & Seaman, K. L. (2023) · Cerebral Cortex Communications · doi:10.1093/texcom/tgad008 · Cited by 2
Hara, R. B. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.48.007688 · Cited by 2
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA
Alexander, G. D., Cavanah, L. R., Goldhirsh, J. L., Huey, L. Y., & Piper, B. J. (2023) · Pharmacopsychiatry · doi:10.1055/a-2152-7757 · Cited by 2
Self-citationBass, B., & Vann, L. J. (2024) · Mental Health Clinician · doi:10.9740/mhc.2024.02.017 · Cited by 2
Davis-Ewart, L., Atkins, L., Ghanooni, D., Diaz, J. E., Chuku, C. C., Balise, R. R., DeVries, B., Miller-Perusse, M., Ackley, D., Moskowitz, J. T., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-19745-7 · Cited by 2
New Perspectives on Risk Factors for Exertional Heat Stroke
Morrissey, M. C., Szymanski, M. R., Grundstein, A., & Casa, D. J. (2020) · Kinesiology Review · doi:10.1123/kr.2019-0064 · Cited by 2
Vohra, V., King, A. M., Daviskiba, S. E., Reed, B. P., Rockhill, S. M., Kern, P., & Dean, D. J. (2020) · Clinical Toxicology · doi:10.1080/15563650.2020.1853143 · Cited by 2
Specific Anthropology of Vulnerabilities, Substance Misuse, Addiction and Secondary Psychoses
Messas, G. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-62724-9_7 · Cited by 2
Clinical Aspects of Breast Cancer
Karrar, H. R., Nouh, M. I., Alanazi, B. M., Hakami, A. O. A., Alzahrani, W. J. S., Aldoweirah, W. K., Alanazi, W. S., Alshammari, N. E., Alanazi, B. M., Alharbi, R. A., et al. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525148 · Cited by 2
Jiang, Z., Zhang, T., Han, W., Xiao, J., Zhang, W., Wang, X., Liu, J., Yang, Y., Yang, C., Guan, F., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1217382 · Cited by 2
Rise and Regional Variations in Schedule II Stimulant Use in the United States
.Vaddadi, S. M., Czelatka, N. J., Gutierrez, B. D., Maddineni, B. C., Torres-Teran, C. D., Tron, D. N., McCall, K. L., & Piper, B. J. (2020) · Scholarly Research In Progress · doi:10.64057/001c.142567 · Cited by 2
Self-citationThe Benefits of Outdoor Education for Students with Attention-Deficit Hyperactivity Disorder
Winking, A. (2023) · doi:10.15760/honors.1346 · Cited by 2
Piacentino, D., Rossi, P. D., Kotzalidis, G. D., Maniscalco, I., Pompili, M., Giupponi, G., Hiemke, C., & Conca, A. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2740 · Cited by 1
Mindfulness-Based Programs for Children with Developmental Challenges
Lo, H. H. M. (2024) · Mindfulness in behavioral health · doi:10.1007/978-3-031-51943-7_5 · Cited by 1
Measures of stimulant medications: A population-based study in Alberta, Canada
Dubois, C., Ye, M., Weaver, O. R., Samanani, S., Jess, E., Gilani, F., & Eurich, D. T. (2024) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2024.100159 · Cited by 1
Diagnosis and Management of Comorbid ADHD in Patients with Substance Use Disorders
Busch, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-72219-6_50 · Cited by 1
Protective Effects of ADHD Medication on Real-World Outcomes
Sultan, R. S., Saunders, D. C., & Veenstra-VanderWeele, J. M. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0918 · Cited by 1
Short, H., Lehman, E. B., Nelluri, S., Latronica, J. R., & Bali, B. (2026) · Cureus · doi:10.7759/cureus.104712 · Cited by 1
Decline and Pronounced Regional Disparities in Medical Cocaine Usage in the United States
Armbuster, Y. C., Banas, B. N., Feickert, K. D., England, S. E., Moyer, E. J., Christie, E., Chughtai, S., Giuliani, T. J., Halden, R. U., Graham, J., et al. (2021) · Journal of Pharmacy Technology · doi:10.1177/87551225211035563 · Cited by 1
Self-citationMoattari, C. R., & França, K. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14669_g · Cited by 1
Ali, A. A., Aledili, F. J., Albahrani, F., Albisher, H., Bomouzah, F. A., Aleliwi, F., Alghasham, G., & Alalawi, L. Y. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525138 · Cited by 1
Sari, S. A. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525144 · Cited by 1
Psychoneurotic symptoms among COVID infected patients; case series study
Ibraheem, M. K., Abedalrahman, S. K., & Sarhat, A. R. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525143 · Cited by 1
Concomitant COVID 19 Infection And NTDS: 68 Patient Case Series
Abedalrahman, S. K., Khalid, F. K., Ali, M. S., & Hasan, S. M. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525142 · Cited by 1
Awareness of benign paroxysmal positional vertigo among the population of Taif city
Basurrah, M. A., Fageeh, Y. A., Alziyadi, S. H., AlShehri, A. M., Alrabie, W. K., Alruways, M. M., Alosaimi, A. S., & Alfadli, F. M. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525140 · Cited by 1
Health-related behaviors of undergraduate medical students of public sector university, Karachi 2022
Aijaz, S., Karim, A. J., Abid, F., Azhar, A., Noor, M., & Muhammad, S. A. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525139 · Cited by 1
Ateeq, N. F. S. A., Aljalban, B. A. M., Alazmi, N. F. S., Aljalban, A. A. M., Alharbi, T. A. A., & Alanazi, M. R. R. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525156 · Cited by 1
Alzahrani, K. M., Abdelrahman, T. M., Jafri, S. A., Abdo, M. S., & Alsharif, K. A. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525135 · Cited by 1
The monitoring of DOACs in primary care, a quality improvement project
Muhid, A., & Khan, J. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525136 · Cited by 1
Ramdin, C., Bikkina, R., Nelson, L. S., & Mazer-Amirshahi, M. E. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.01.042 · Cited by 1
Rizvi, A., Husain, K., Usmani, M. A., Trivedi, C. G., Jain, B., Ashraf, S., & Safwi, S. R. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115426 · Cited by 1
Rethinking drug-related harms as emerging through global systems
Caluzzi, G., & Norman, T. L. (2025) · Addiction Research & Theory · doi:10.1080/16066359.2025.2554645 · Cited by 1
Pediatric Primary Care Providers Play a Central Role in Reducing Stimulant Diversion
Antshel, K. M. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.01.003 · Cited by 1
Central Nervous System Stimulants and Drugs That Suppress Appetite
Bello, N. T., & Zahner, M. R. (2017) · Side effects of drugs annual · doi:10.1016/bs.seda.2017.07.007
Methamphetamine psychosis: Lack of association with stimulant prescription ADHD medications
Mann, D. M., Marco, C. A., Detherage, J. P., Greene, P. J., & Ross, D. E. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.03.018
A Resource Guide on the Epidemiology, Prevention, and Treatment of Opioid and Other Substance Use.
Rotoloni, A. F. (2019) · Digital Archive @ GSU · doi:10.57709/15063747
Never Exposed to Nicotine - But Still Impacting Executive Function
Piper, B. J., & Wilcox, B. D. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.01.053
Self-citationFairman, K. A. (2020) · ScholarWorks (Walden University)
New Developments in Behavioral Pharmacology
Cueto‐Escobedo, J., García‐García, F., Maximino, C., & Rodríguez‐Landa, J. F. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93700
Narcolepsy in Childhood, A Literature Review
al., T. M. E. A. T. M. E., & TJPRC (2020) · International journal of educational science and research · doi:10.24247/ijesraug202016
von Heydwolff, A. (2021) · psychopraxis neuropraxis · doi:10.1007/s00739-021-00693-5
Sivonen, W., & Craciun, A. (2020) · Theseus (Ammattikorkeakoulujen)
Utilisation and outcomes of treatment in Autism Spectrum Disorder
Houghton, R. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210304rh
HEADACHE – Common symptom with Rare Diagnosis in UK Primary Care – A Case report
Raza, S. M., & Haque, S. S. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525153
Efficacy of oral isotretinoin in the treatment of acne vulgaris
Al-Zou, A. O. B., Saleh, A. H. A., Bafadhl, M. S., & Elkasah, F. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525134
Prevalence of depressive symptoms in hypertensive patients in Taif city
Atalla, A. A., AlQarni, R. S., Althubaiti, R. S., Alhasani, K. A., Alghamdi, B. S., & Alghamdi, H. S. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525131
Shen, D., Jiao, J., Zhang, L., Liu, Y., Liu, X., Li, Y., Zhang, T., Li, D., & Hao, W. (2023) · medRxiv · doi:10.1101/2023.08.22.22279466
Nonmedical Use of Prescription Stimulants and Nicotine Among Community College Students
Truitt, H. G., Ginley, M. K., Foster, K. N., Sevak, R. J., & Hagemeier, N. E. (2024) · Community College Review · doi:10.1177/00915521231218208
Medical Marijuana Had No Impact on Amphetamine Prescribing in MedicaidPreprint
Williams, E. M., Camara, M., Goldhirsh, J. L., & Piper, B. J. (2024) · medRxiv · doi:10.1101/2024.01.27.24301085
Self-citationRode, B. S. (2022) · ResearchSpace (University of KwaZulu-Natal) · doi:10.29086/10413/22738
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA
Alexander, G. D., Cavanah, L. R., Goldhirsh, J. L., Huey, L. Y., & Piper, B. J. (2024) · Pharmacopsychiatry · doi:10.1055/a-2334-6253
Self-citationTuan, W., Rago, A. V., Heron, C., Partin, M., Burke, K., Hwang, G., & Zgierska, A. E. (2024) · Medical Research Archives · doi:10.18103/mra.v12i9.5807
Relationship of Amphetamines in Reducing Substance Abuse Risks Among ADHD Patients
Deng, A., & Espiridion, E. D. (2024) · Transformative Medicine · doi:10.54299/tmed/neui7615
Exploring prevention strategies and treatment in addictive disorders
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5978-9
Drug Treatment of other Psychiatric Conditions
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg009.pub2
Reaching ADHD Treatment Targets?
Dalsgaard, S., Posserud, M.-B. R., Miskowiak, K. W., & Man, K. K. C. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13815
Achtsamkeitsbasierte Programme für Kinder mit Entwicklungsproblemen
Lo, H. H. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-83285-7_5
Eisman, A. B., Hubbell, A., & Boyd, C. J. (2025) · Journal of Child & Adolescent Substance Use · doi:10.1080/29973368.2025.2502878
Yamashiro, A. S. (2025) · Eventos Pedagógicos · doi:10.30681/reps.v16i1.13401
Mezzedimi, L. P. B., Hiluy, M. F. F., Farias, D. T., Martins, R. D., & Rocha, C. C. O. E. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n9-106
Demographic and Genetic Predictors of ADHD Diagnoses and Medications in Electronic Health RecordsPreprint
Nicastro, O. R., Reed, M., Jinwala, Z., BioBank, P. M., Kember, R. L., & Hartwell, E. E. (2025) · Research Square · doi:10.21203/rs.3.rs-7520845/v1
Davis-Ewart, L., Atkins, L., Ghanooni, D., Diaz, J. E., Chuku, C. C., Balise, R. R., DeVries, B., Miller-Perusse, M., Ackley III, D., Moskowitz, J. T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26944041
Antoniou, T., McCormack, D., Kitchen, S. A., PAJER, K. A., Gardner, W. P., Lunsky, Y., Penner, M., Tadrous, M., Mamdani, M., Juurlink, D. N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22610158
Antoniou, T., McCormack, D., Kitchen, S. A., PAJER, K. A., Gardner, W. P., Lunsky, Y., Penner, M., Tadrous, M., Mamdani, M., Juurlink, D. N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22610161
McMenamin, S. B., Abbott, B., Pantely, S., Coughlin, L. N., Lewis, J., & Garibay, V. (2020) · eScholarship (California Digital Library) · doi:10.13140/rg.2.2.32072.85766
Évolution des prescriptions de méthylphénidate en région Occitanie de 2013 à 2021
Velay, A. (2024) · HAL
Hyperactivity disorder (ADHD) : assessment and rehabilitation techniques
Δήμου, Α. Σ., & Δήμου, Α. Σ. (2024) · University of Thessaly Institutional Repository (University of Thessaly)
Subjective Gender-Based Patterns in ADHD DiagnosisPreprint
Bertoni, M., Marin-Lopez, B. A., & Sanz‐de‐Galdeano, A. (2023) · RePEc: Research Papers in Economics
Trends and Regional Differences in the Diversion of Stimulants in the United States, 2015–2019
Funk, H. E., Pitt, S. E., Varano, A. T., & Piper, B. J. (2021) · Scholarly Research In Progress · doi:10.64057/001c.142411
Self-citationChanges in Prescription and Illicit Stimulant Use in the United States, 2014 to 2018
Boyle, J. M., Funk, H. E., Pitt, S. E., Varano, A. T., Vaddadi, S., Piper, B. J., & McCall, K. L. (2020) · Scholarly Research In Progress · doi:10.64057/001c.154617
Self-citationBeyond the label: identifying modifiable predictors of ADHD-like adaptation in young adults
Alp, A., Kandeğer, A., Benekli, Z. N., Ertekin, İ., Akbulut, D., Dinçer, B., Uçar, D., & Demir, B. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116927
AI tools for automating personalised and participatory evidence-based treatment recommender systems
Casanova, Ò. R. I. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Prescription stimulant consumption in the United States compared with 35 other countries
Bachhuber, M. A., Jordan, A. E., & Piper, B. J. (2026) · Health Affairs Scholar · doi:10.1093/haschl/qxag133
Self-citationMammadzada, G. (2026) · Azərbaycan Psixiatriya Jurnalı · doi:10.66642/bhrl2429
Ruwel, A. G., Pio, R. P., Alves, I. N. L., Tardelli, V. S., & Kessler, F. H. P. (2026) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2026-4806
Rzeszutek, M., Konowałek, Ł., Martin, J., Butwicka, A., & Wolańczyk, T. (2026) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-026-03104-5
Guez, E., van der Waerden, J. E. B., Cohen, D., & Benarous, X. (2026) · BMC Public Health · doi:10.1186/s12889-026-28213-3
Benz, M. B., Rieke, K., Sereda, Y., Mai, H. J., Rudolph, J. L., Dew, R. E., Primack, J. M., McGeary, J. E., Rickard, T., Trikalinos, T. A., et al. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261493758
Vilhem, S. (2026) · Journal de la psychanalyse de l enfant · doi:10.3917/jpe.031.0107
Jiang, Z., Zhang, T., Han, W., Xiao, J., Zhang, W., Wang, X., Liu, J., Yang, Y., Yang, C., Guan, F., et al. (2023) · doi:10.3389/fphar.2023.1217382.s001
Metadata
- Authors
- Piper, B. J., Ogden, C. L., Simoyan, O. M., Chung, D. Y., Caggiano, J. F., Nichols, S. D., & McCall, K. L.
- Affiliations
- Geisinger College of Health Sciences (US)
- Tufts University (US)
- University of New England (US)
- Corresponding author
- Piper, Brian J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-28
- Volume
- 13
- Issue
- 11
- Pages
- e0206100
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6261411
- OpenAlex
- W2903069810
- Cited by
- 170
- References
- 85
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 15 · 2023: 27 · 2022: 42 · 2021: 24 · 2020: 23 · 2019: 6
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Environmental Health Sciences (T32 ES007060-31A1)
- Husson University School of Pharmacy (2013-01)
- Fahs-Beck Fund for Research and Experimentation (2017-01)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant medication, amphetamine, methylphenidate, lisdexamfetamine, methamphetamine, ADHD medication, drug diversion, regional disparities, Hispanic population, pharmacoepidemiology, controlled substances, drug use trends, Southern United States, northeastern United States, ethnic disparities
- MeSH terms
- Central Nervous System Stimulants, Geography, Humans, United States, United States Food and Drug Administration, Prescriptions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.